The Efficacy of Safinamide in the Management of Parkinson's Disease: A Systematic Review

Parkinson's disease (PD) is a chronic neurodegenerative disease that is challenging to treat due to its progressive nature and its weaning response to therapy. Safinamide, a monoamine oxidase type-B inhibitor (MAOB-I), has shown promise in managing dyskinesias caused by levodopa (L-dopa), carbi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharaf, Joudi, Williams, Kerry-Ann D, Tariq, Maha, Acharekar, Maitri V, Guerrero Saldivia, Sara E, Unnikrishnan, Sumedha, Chavarria, Yeny Y, Akindele, Adebisi O, Jalkh, Ana P, Eastmond, Aziza K, Shetty, Chaitra, Rizvi, Syed Muhammad Hannan A, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559607/
https://www.ncbi.nlm.nih.gov/pubmed/36259026
http://dx.doi.org/10.7759/cureus.29118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559607/
https://www.ncbi.nlm.nih.gov/pubmed/36259026
http://dx.doi.org/10.7759/cureus.29118

Ejemplares similares